eAGR2 expression has been identified in pancreatic cancer [16], gastrointestinal mucinous tumors [77], and prostate cancer models [78], where AGR2 is directly expressed within the TME and secreted by cancer cells [40]. This evidence concerns the gene AGR2 and prostate carcinoma.